St. Jude researchers revealed that midkine blocks amyloid beta from forming harmful clumps linked to Alzheimer’s. Without it, the damaging assemblies accelerate, but with it, growth halts. The finding could inspire new drugs that harness midkine’s protective power.
Yes, but any treatment derived from it will very probably be priced out of the reach of most American’s without top shelf insurance.